Characterization of diverse Cas9 orthologs for genome and epigenome editing
Proceedings of the National Academy of Sciences · 18.03.2025 · 122 (11)
DOI: 10.1073/pnas.2417674122 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 12.03.2025. Verfasst von Gabriel L Butterfield und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, and Center for Advanced Genomic Technologies, Duke University, Durham, NC 27708. Hauptthemen laut MEDLINE: Gene Editing, CRISPR-Cas Systems, CRISPR-Associated Protein 9, Epigenome. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIMH NIH HHS, HHS | NIH (NIH), NHGRI NIH HHS.
Abstract (Originalsprache)
CRISPR-Cas9 systems have revolutionized biotechnology, creating diverse new opportunities for biomedical research and therapeutic genome and epigenome editing. Despite the abundance of bacterial CRISPR-Cas9 systems, relatively few are effective in human cells, limiting the overall potential of CRISPR technology. To expand the CRISPR-Cas toolbox, we characterized a set of type II CRISPR-Cas9 systems from select bacterial genera and species encoding diverse Cas9s. Four systems demonstrated robust and specific gene repression in human cells when used as nuclease-null dCas9s fused with a KRAB domain and were also highly active nucleases in human cells. These systems have distinct protospacer adjacent motifs (PAMs), including AT-rich motifs and sgRNA features orthogonal to the commonly used Staphylococcus aureus and Streptococcus pyogenes Cas9s. Additionally, we assessed gene activation when fused with the p300 catalytic domain. Notably, S. uberis Cas9 performed competitively against benchmarks with promising repression, activation, nuclease, and base editing activity. This study expands the CRISPR-Cas9 repertoire, enabling effective genome and epigenome editing for diverse applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Engineering, and Center for Advanced Genomic Technologies, Duke University, Durham, NC 27708.
- Department of Food, Bioprocessing and Nutrition Sciences, North Carolina State University, Raleigh, NC 27606.
ORCID-Profile: Gabriel L Butterfield, Rodolphe Barrangou
Förderung
- NIMH NIH HHS
- HHS | NIH (NIH)
- NHGRI NIH HHS
- DOD | ARPA | Defense Sciences Office, DARPA (DSO)
- NIAID NIH HHS
- NCI NIH HHS
- NSF (NSF)
Zitieren
APA
Butterfield, G. L., Rohm, D., Roberts, A., Nethery, M. A., Rizzo, A. J., Morone, D. J., Garnier, L., Iglesias, N., Barrangou, R., & Gersbach, C. A. (2025). Characterization of diverse Cas9 orthologs for genome and epigenome editing. Proceedings of the National Academy of Sciences, 122(11). https://doi.org/10.1073/pnas.2417674122
Vancouver
Butterfield GL, Rohm D, Roberts A, Nethery MA, Rizzo AJ, Morone DJ, et al. Characterization of diverse Cas9 orthologs for genome and epigenome editing. Proceedings of the National Academy of Sciences. 2025;122(11). doi:10.1073/pnas.2417674122
BibTeX
@article{Butterfield2025,
author = {Butterfield, Gabriel L and Rohm, Dahlia and Roberts, Avery and Nethery, Matthew A and Rizzo, Anthony J and Morone, Daniel J and Garnier, Lisa and Iglesias, Nahid and Barrangou, Rodolphe and Gersbach, Charles A},
title = {Characterization of diverse Cas9 orthologs for genome and epigenome editing},
journal = {Proceedings of the National Academy of Sciences},
year = {2025},
volume = {122},
number = {11},
doi = {10.1073/pnas.2417674122}
}
EUVIMED